Clinical Trials of America's CEO & Chief Medical Officer Presents at MAGI's Clinical Research Conference - 2010 West
Dr. Richard Beyerlein, CEO and chief medical officer of Clinical Trials of America, explains how to be a clinical researcher's "sponsor of choice."
- (1888PressRelease) October 15, 2010 - Eugene, Ore. - Clinical Trials of America's CEO & Chief Medical Officer Presents at MAGI's Clinical Research Conference - 2010 West
Dr. Richard Beyerlein explains how to be a clinical researcher's "sponsor of choice"
Dr. Richard Beyerlein, founder, CEO and chief medical officer of Clinical Trials of America, will speak at the Model Agreements and Guidelines International's (MAGI) Clinical Research Conference - 2010 West from 3:45 p.m. to 4:30 p.m. on Monday, Oct. 25 at the Fairmont Hotel in San Francisco.
Beyerlein will discuss the relationship between a sponsor and a clinical trials business during a presentation titled "What Sites Want from Sponsors: How to Become a 'Sponsor of Choice.'" The program will explore some of the ways sponsors can help simplify the complexities of operating a full-service clinical trials business, including the alignment of incentives and clear communication.
"The MAGI Clinical Research Conference - 2010 West illustrates the importance of having all clinical research participants - physicians, patients, partners and sponsors - working together to create a successful, lucrative and trusted clinical research industry," Beyerlein said. "I look forward to sharing my experiences with Clinical Trials of America with industry professionals and exploring ways we can advance clinical research together."
Beyerlein is an experienced clinical researcher, as well as a board-certified specialist in obstetrics and gynecology and a certified principal investigator at Pacific Women's Center in Eugene, Ore. He is a member of the Association for Clinical Research Professionals and a clinical assistant professor at Oregon Health & Science University. Beyerlein has been honored with an America's Top Obstetricians and Gynecologists award and a Consumer Research Council of America award, and his work has been published in the Journal of American Medical Association, American Journal of Obstetrics and Gynecology and the American Journal of Obstetrics.
The MAGI Clinical Research Conference - 2010 West is scheduled for Oct. 24 through Oct. 27 and features 92 clinical trial program sessions and workshops, including elements of sponsor and site operations and program ethics, contracts, budgets and billing. Session dates and times can be found on the MAGI agenda page.
Operated by First Clinical Research, MAGI represents 5,000 clinical research organizations, sites and sponsors. As part of its mission to standardize best practices for clinical research operations, business and regulatory compliance, First Clinical Research and The International Institute for Business Information and Growth present conferences with nearly 100 sessions and workshops offering industry tips on clinical research operations.
To register and learn more about MAGI's Clinical Research Conference - 2010 West, visit www.magiworld.org.
Clinical Trials of America
A physician-founded and operated clinical trials company, the Clinical Trials of America team has more than 90 years of combined experience. The company's investigators, research coordinators and support staff have performed more than 450 combined clinical trials and have provided services to more than 45 pharmaceutical companies and 15 contract research organizations. The company works with a network of experienced principal investigators from specialties including endocrinology, family practice, gastroenterology, gynecology, neurology, ophthalmology, perinatology, psychiatry, radiology, urgent care and urology. More information is available at www.ctofa.com.
Contact: Don Dickerson, Clinical Trials of America, (541) 349-0523, ddickerson ( @ ) ctofa dot com
Monica Shovlin, The Ulum Group, (541) 434-7028, mshovlin ( @ ) ulum dot com
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam